 Oncternal Therapeutics, Inc. Nasdaq: ONCT, a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report second quarter 2020 financial results after U.S. financial markets close on Thursday, August 6, 2020. Oncternals management will host a webcast at 2:00 p.m. PT 5:00 p.m. ET to discuss the Companys financial results and provide a comprehensive business update. 